Growth Metrics

Biomerica (BMRA) Capital Expenditures (2016 - 2024)

Biomerica's Capital Expenditures history spans 15 years, with the latest figure at $24000.0 for Q2 2024.

  • On a quarterly basis, Capital Expenditures changed N/A to $24000.0 in Q2 2024 year-over-year; TTM through May 2024 was $51000.0, a 20.31% decrease, with the full-year FY2024 number at $51000.0, down 20.31% from a year prior.
  • Capital Expenditures hit $24000.0 in Q2 2024 for Biomerica, up from $6000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for BMRA hit a ceiling of $45194.0 in Q1 2021 and a floor of $5141.0 in Q3 2021.
  • Historically, Capital Expenditures has averaged $20946.3 across 5 years, with a median of $21689.5 in 2020.
  • Biggest five-year swings in Capital Expenditures: surged 1723.49% in 2020 and later plummeted 87.01% in 2021.
  • Tracing BMRA's Capital Expenditures over 5 years: stood at $21978.0 in 2020, then tumbled by 40.53% to $13071.0 in 2021, then skyrocketed by 83.61% to $24000.0 in 2022, then crashed by 75.0% to $6000.0 in 2023, then soared by 300.0% to $24000.0 in 2024.
  • Business Quant data shows Capital Expenditures for BMRA at $24000.0 in Q2 2024, $6000.0 in Q4 2023, and $21000.0 in Q3 2023.